In the Pipeline: Tivozanib Tops Placebo in Renal Cell Carcinoma - Internal Medicine News Digital Network PDF Print
Internal Medicine News Digital NetworkData Source: A trial of 272 patients with advanced renal cell carcinoma who had not received any previous anti-VEGF therapy. Disclosures: The study was

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.